-
Almost one-fifth of Medicare patients who were discharged from a hospital were rehospitalized within 30 days, and about a third were rehospitalized within 90 days. Most of these readmissions were not planned.
-
Everolimus is the newest oral kinase inhibitor approved for the treatment of advanced renal cell carcinoma.
-
The ACCORD trial has been newsworthy in the last several months primarily due to the early results of increased cardiovascular events associated with very tight glucose control.
-
The simultaneously obtained lead II and lead V1 rhythm strip seen above was interpreted as showing atrial fibrillation with a rapid ventricular response. Do you agree?
-
Most type 2 diabetics (DM2) who undergo bariatric surgery enjoy a prompt reversal or at least a substantial diminution of their dysglycemia.
-
Use of statins as primary prevention in healthy people with elevated high-sensitivity C-reactive protein without hyperlipidemia may reduce the incidence of major cardiovascular events.
-
Oral antibiotics were not found to be inferior to intravenous antibiotics in the treatment of clinically diagnosed acute diverticulitis.
-
Compared with invasive coronary angiography, coronary computed tomographic angiography demonstrated high diagnostic accuracy for detection of obstructive coronary stenosis and a 99% negative predictive value.
-
A new transdermal formulation of oxybutynin has been approved for the treatment of overactive bladder. Oxybutynin gel is marketed by Watson Pharmaceuticals as Gelniqueä.
-
A severe ankle sprain (ANK-S) might seem like a minor injury, but clinicians may be underestimating the burden of consequence.
